Lates News

According to Every star AI News, Pu Yin International Securities released a research report on April 29th, giving a buy rating to Wuhan Health Conde (603259.SH) with a target price of 93 yuan. The reasons for the rating include: 1) the company's 1Q25 performance significantly exceeded expectations; 2) strong revenue growth driven by continued growth in small molecule D&M revenue and strong growth in TIDES business; 3) early business is expected to remain weak in the first half of the year; 4) tariff impact is controllable, maintaining the full year guidance for 2025. (Daily Economic News)